Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells
22 nov. 2021 02h00 HE | Immunicum AB
Press ReleaseStockholm, Sweden, November 22, 2021Immunicum Publishes DCP-001 Mechanism of Action in the Journal CellsImmunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat...
Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften Cells
22 nov. 2021 02h00 HE | Immunicum AB
Pressmeddelande22 november 2021 Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften CellsImmunicum AB (publ; IMMU.ST), ett biofarmaceutiskt företag fokuserat på svårbehandlade solida...
Diverse: Issues In Higher Education Launches Revamped Website Marking Nearly Half a Century of Publishing
17 nov. 2021 14h59 HE | Diverse Education
Fairfax, Va., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Diverse: Issues In Higher Education has revitalized its online platform – improving the visitor experience, increasing partner visibility and...
logo.jpg
ImCheck Publishes Comprehensive Overview of the Development Results of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cells in Science Translational Medicine
20 oct. 2021 14h21 HE | ImCheck Therapeutics SAS
ImCheck Publishes Comprehensive Overview of the DevelopmentResults of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cellsin Science Translational Medicine ...
Learning from our Mistakes: Equipping Nations to Meet Biological Diversity Goals
28 janv. 2021 09h10 HE | NatureServe
Washington, DC, Jan. 28, 2021 (GLOBE NEWSWIRE) -- NatureServe’s Director of Biodiversity Indicators Program, Mike Gill, collaborated with researchers from China and Germany to complete a pivotal...
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
07 janv. 2021 14h15 HE | BioNTech SE
Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA...
BioNTech veröffentlicht Daten zu neuartigem mRNA-Impfstoffansatz gegen Autoimmunkrankheiten in Science
07 janv. 2021 14h15 HE | BioNTech SE
Gemeinsame Studie von BioNTech, TRON und der Universitätsmedizin sowie dem Forschungszentrum für Immuntherapie der Johannes Gutenberg-Universität Mainz untersucht neuartigen entzündungshemmenden...
logo_new_alexis_withTag_withTMTM_72dpi_0 (002).jpg
Livanta Wins Highest Honor in 2020 MarCom Awards
28 oct. 2020 16h00 HE | Livanta LLC
ANNAPOLIS JUNCTION, Md., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Livanta LLC announced today that the firm has been recognized internationally for excellence in the development of communications products...
Cyclacel Pharmaceuticals logo
Cyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in Cancer
13 juil. 2020 07h00 HE | Cyclacel
-- Characterization of fadraciclib published in peer-reviewed journal shows specificity against CDK2 and CDK9 and enablement of apoptosis of cancer cells driven by MCL1, cyclin E and/or MYC – ...
red.jpg
RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal Medicine
05 mai 2020 07h00 HE | RedHill Biopharma Ltd.
Talicia® is approved by the U.S. FDA and promoted by RedHill’s U.S. sales force--Abstract discussing Talicia pharmacokinetics and exposure-response presented as ePoster at Digestive Disease Week®...